CHOSA Oncology AB (CHOSA.ST)
- Previous Close
0.8300 - Open
0.6800 - Bid 0.7500 x --
- Ask 0.8450 x --
- Day's Range
0.8300 - 0.8300 - 52 Week Range
0.3900 - 1.4000 - Volume
10,418 - Avg. Volume
22,232 - Market Cap (intraday)
58.884M - Beta (5Y Monthly) -0.06
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Chosa Oncology AB develops oncology drugs for the treatment of cancer. The company was formerly known as Chosa ApS. Chosa Oncology AB founded in 2022 and is based in Lund, Sweden.
www.chosaoncology.comRecent News: CHOSA.ST
View MorePerformance Overview: CHOSA.ST
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHOSA.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHOSA.ST
View MoreValuation Measures
Market Cap
58.88M
Enterprise Value
50.11M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
4.26
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-33.72%
Return on Equity (ttm)
-61.44%
Revenue (ttm)
44k
Net Income Avi to Common (ttm)
-9.59M
Diluted EPS (ttm)
-0.1400
Balance Sheet and Cash Flow
Total Cash (mrq)
6.44M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-4.64M